The global Digital Health market was valued at $170.2bn in 2023 and is expected to grow 62%, to over $275bn by 2028 [1]. With traditional health systems often plagued by outdated systems, administrative burden and inefficiency costs, Digital Health solutions seek to alleviate these pain points and support patients in managing their health across the full patient pathway.
Key growth factors include:
- Consumers focussed on convenience: In the UK, 33% of people had to wait a week or more to see their GP in 2024 [2]. As such, consumers are increasingly looking towards online consultations for convenience, cost-effectiveness, and time-saving benefits.
- Improved outcomes through technology: Telemedicine solutions have the potential to promote positive outcomes for patients, for example by detecting early warning signs of deterioration.
- Innovators taking traditional systems fully online: A prime example being the pharmacy industry, which provides digital solutions to support patients obtain prescriptions and receive medication.
- Government involvement in increasing partnerships with private companies: Patients can access NHS GPs and nurses through video consultations and be referred to specialists.
As such, there is an increasing level of PE interest and larger companies entering the Digital Health space, with deal volumes in the sector expected to increase as providers look to consolidate across the value chain.
To learn more about the key M&A trends taking shape this year in the Digital Health space, read our latest paper.
DOWNLOAD THE FULL PAPER
If you would like to know more about the Digital Health M&A landscape after reading this paper, or have any other questions on the wider healthcare space, please do get in touch - asultan@alvarezandmarsal.com. We would be delighted to discuss this report with you, including any implications these current and longer-term market themes may have on your business and overall shareholder objectives.
Sources:
[1] Statista – Digital Health Market Insights Report 2023
[2] Lord Darzi NHS Report
The Evolving MedTech M&A Landscape: Key Drivers and Future Outlook--TEST
February 10, 2025
The MedTech sector is experiencing a dynamic shift as mergers and acquisitions (M&A) continue to reshape the industry. With evolving technological advancements, regulatory updates, and shifting market priorities, companies are leveraging strategic acquisitions to drive growth and maintain competitive advantages. Understanding these factors is essential for MedTech leaders aiming to capitalize on emerging opportunities in 2024 and beyond.
Putting it all together: flexible and innovative financing for a consumer centric renewable energy transition
November 28, 2024
As the EU charges ahead with its ambitious renewable energy targets under the REPowerEU plan, the challenge lies in turning large-scale goals into actionable solutions. Decentralized energy production through home solar panels and heat pumps is a step forward, but the question of financing remains critical. While the U.S. has seen success with solar securitization, Europe faces unique hurdles, from fragmented regulation to consumer diversity. Yet, innovative structured credit solutions offer a tailored path forward, enabling businesses to scale sustainably and unlock new opportunities in green energy financing. Discover how Alvarez & Marsal can guide you through this evolving landscape.
THE OCCUPATIONAL HEALTH M&A MARKET
November 18, 2024
According to the Institute of Public Policy Research, presenteeism, or working whilst sick, cost the UK economy £25bn in 2023, whilst absenteeism cost an additional £5bn. To address these challenges, many workplaces now emphasise proactive, value-added services for employee wellbeing and performance, delivered both on-site and online. This shift has spurred growth in the Occupational Health market, attracting significant interest from financial investors and strategic acquirers.
Alvarez & Marsal hires Tech M&A Managing Director
November 14, 2024
London, 4 November 2024 – Leading global professional services firm Alvarez & Marsal (A&M) continues to strengthen its Corporate Finance practice in the UK with the appointment of Ian Birch as a Managing Director in Birmingham. At A&M, he will build out the practice’s technology M&A capability across Europe.
